Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosome binding domain 1 pseudogene 13 (HMGN1P13) is a human pseudogene with sequence similarity to the HMGN1 gene, which encodes a chromatin-associated protein. Pseudogenes like HMGN1P13 are typically nonfunctional DNA sequences that do not encode active proteins, often arising from gene duplication or retrotransposition events[2][4]. Although classically considered "junk DNA," emerging evidence indicates that some pseudogenes can regulate related protein-coding genes, mainly via noncoding RNA mechanisms such as acting as competing endogenous RNAs or influencing mRNA stability[1][2]. However, there is no established protein function, therapeutic relevance, or disease association specifically for HMGN1P13[4]. The gene is referenced under NCBI Gene ID: 100874439. If the intent was to identify a receptor or protein-coding therapeutic target, then HMGN1P13 is not appropriate: it is a noncoding pseudogene. For the functional protein, refer to the High mobility group nucleosome binding domain 1 (HMGN1) gene, not its pseudogene variant.
None known; not targeted by therapeutic drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 13 (HMGN1P13).